Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.74% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 57.67% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -44.49% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -27.15% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 3.59% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | -34,000.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,000.00% |
| Dec 31, 2025 | 81.41% |
| Sep 30, 2025 | -23.98% |
| Jun 30, 2025 | -800.54% |
| Mar 31, 2025 | 99.62% |
| Dec 31, 2024 | -36.22% |
| Sep 30, 2024 | 63.95% |
| Jun 30, 2024 | 68.39% |
| Mar 31, 2024 | 52.47% |
| Dec 31, 2023 | 26.24% |
| Sep 30, 2023 | -74.64% |
| Jun 30, 2023 | -723.40% |
| Mar 31, 2023 | -166.83% |
| Dec 31, 2022 | -456.58% |
| Sep 30, 2022 | -242.68% |
| Jun 30, 2022 | -200.00% |
| Mar 31, 2022 | 48.10% |
| Dec 31, 2021 | 85.69% |
| Sep 30, 2021 | 261.84% |
| Jun 30, 2021 | 91.53% |